AAAAAA

   
Results: 1-7 |
Results: 7
Adamantylaminopyrimidines and -pyridines are potent inducers of tumor necrosis factor-alpha
Authors: Kazimierczuk, Z Gorska, A Switaj, T Lasek, W
Citation: Z. Kazimierczuk et al., Adamantylaminopyrimidines and -pyridines are potent inducers of tumor necrosis factor-alpha, BIOORG MED, 11(9), 2001, pp. 1197-1200
Potentiated antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo
Authors: Golab, J Zagozdzon, R Kaminski, R Kozar, K Gryska, K Izycki, D Mackiewicz, A Stoklosa, T Giermasz, A Lasek, W Jakobisiak, M
Citation: J. Golab et al., Potentiated antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo, LEUKEMIA, 15(4), 2001, pp. 613-620
Potentiatied anti-tumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivo
Authors: Golab, J Zagozdzon, R Kozar, K Kaminski, R Giermasz, A Stoklosa, T Lasek, W Jakobisiak, M
Citation: J. Golab et al., Potentiatied anti-tumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivo, ONCOL REP, 7(1), 2000, pp. 177-181
Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in mice
Authors: Lasek, W Mackiewicz, A Czajka, A Switaj, T Golab, J Wiznerowicz, M Korczak-Kowalska, G Bakowiec-Iskra, EZ Gryska, K Izycki, D Jakobisiak, M
Citation: W. Lasek et al., Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in mice, CANC GENE T, 7(12), 2000, pp. 1581-1590
Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice
Authors: Golab, J Kozar, K Kaminski, R Czajka, A Marczak, M Switaj, T Giermasz, A Stoklosa, T Lasek, W Zagozdzon, R Mucha, K Jakobisiak, M
Citation: J. Golab et al., Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice, LIFE SCI, 66(13), 2000, pp. 1223-1230
Potentiation of the anti-tumour effects of Photofrin (R)-based photodynamic therapy by localized treatment with G-CSF
Authors: Golab, J Wilczynski, G Zagozdzon, R Stoklosa, T Dabrowska, A Rybczynska, J Wasik, M Machaj, E Oldak, T Kozar, K Kaminski, R Giermasz, A Czajka, A Lasek, W Feleszko, W Jakobisiak, M
Citation: J. Golab et al., Potentiation of the anti-tumour effects of Photofrin (R)-based photodynamic therapy by localized treatment with G-CSF, BR J CANC, 82(8), 2000, pp. 1485-1491
Subtherapeutic doses of interleukin-15 augment the anti-tumor effect of interleukin-12 in a B16F10 melanoma model in mice
Authors: Lasek, W Golab, J Maslinski, W Switaj, T Balkowiec, EZ Stoklosa, T Giermasz, A Malejczyk, M Jakobisiak, M
Citation: W. Lasek et al., Subtherapeutic doses of interleukin-15 augment the anti-tumor effect of interleukin-12 in a B16F10 melanoma model in mice, EUR CYTOKIN, 10(3), 1999, pp. 345-356
Risultati: 1-7 |